What's new in clinical transfusion practice

被引：2

作者：

Pink, JM ^{[1
]}

Isbister, JP ^{[1
]}

机构：

[1] ROYAL N SHORE HOSP,DEPT HAEMATOL & TRANSFUS MED,SYDNEY,NSW,AUSTRALIA

来源：

MEDICAL JOURNAL OF AUSTRALIA | 1996年 / 165卷 / 01期

关键词：

D O I：

10.5694/j.1326-5377.1996.tb124814.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Although the Australian blood supply is among the safest in the world, homologous transfusion is not risk-free. In some circumstances, alternatives are available or being developed. Clinicians need to be aware of the risks, benefits and options in transfusion therapy and to fully inform patients of these.

引用

页码：30 / 34

页数：21

共 34 条

[1] THE TUMOR GROWTH-PROMOTING EFFECT OF ALLOGENEIC BLOOD-TRANSFUSIONS [J].

BLAJCHMAN, MA ;

BORDIN, JO .

IMMUNOLOGICAL INVESTIGATIONS, 1995, 24 (1-2) :311-317

[2] A COMPARISON OF FILTERED LEUKOCYTE-REDUCED AND CYTOMEGALOVIRUS (CMV) SERONEGATIVE BLOOD PRODUCTS FOR THE PREVENTION OF TRANSFUSION-ASSOCIATED CMV INFECTION AFTER MARROW TRANSPLANT [J].

BOWDEN, RA ;

SLICHTER, SJ ;

SAYERS, M ;

WEISDORF, D ;

CAYS, M ;

SCHOCH, G ;

BANAJI, M ;

HAAKE, R ;

WELK, K ;

FISHER, L ;

MCCULLOUGH, J ;

MILLER, W .

BLOOD, 1995, 86 (09) :3598-3603

[3]

BRECHER ME, 1991, SEMIN HEMATOL, V28, P3

[4] FIBRIN GLUE [J].

BRENNAN, M .

BLOOD REVIEWS, 1991, 5 (04) :240-244

[5] RECOMBINANT COAGULATION-FACTOR PRODUCTS [J].

BRETTLER, DB .

HAEMOPHILIA, 1995, 1 (03) :155-158

[6] AUTOLOGOUS BLOOD AND INFECTIONS AFTER COLORECTAL SURGERY [J].

BUSCH, ORC ;

HOP, WCJ ;

MARQUET, RL ;

JEEKEL, J .

LANCET, 1994, 343 (8898) :668-668

[7]

CALDER L, 1991, NEW ZEAL MED J, V104, P427

[8]

COFFIN C, 1989, TRANSFUSION, V294, P298

[9]

DAVID LH, 1993, BRIT MED J, V307, P517

[10]

DZIK WH, 1985, ARCH SURG-CHICAGO, V120, P946

← 1 2 3 4 →